EMBRACING FUTURE BIOMEDICAL PTE. LTD.
Country of registration | Singapore |
Registration number | 202447026C |
Local SIC | |
Incorporation date | 15 Nov 2024 |
Company age | 1 year 6 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 5 |
Contact
122 EMERALD HILL ROAD, Singapore 229405
This is the legal entity page of EMBRACING FUTURE BIOMEDICAL PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- View MoreBiolidics is a medical technology company focused on developing cell enrichment systems for cancer diagnosis, prognosis, treatment selection, and treatment monitoring. Our patented technology, the ClearCell® FX1 System, separates and enriches cancer cells from blood samples, providing a simple and minimally invasive alternative to tissue biopsies. With installations in multiple countries, our technology has numerous applications throughout the cancer journey, from screening and staging to personalized treatment and post-cancer monitoring.
Frequently Asked Questions (FAQ)
- What is the address of EMBRACING FUTURE BIOMEDICAL PTE. LTD.?
- Where is EMBRACING FUTURE BIOMEDICAL PTE. LTD.'s headquarter?
- What is EMBRACING FUTURE BIOMEDICAL PTE. LTD.'s contact number?
- What EMBRACING FUTURE BIOMEDICAL PTE. LTD.'s spending power?
- Does EMBRACING FUTURE BIOMEDICAL PTE. LTD. have a presence in the domain it operates in?

